Eryptosis as an Underlying Mechanism in Systemic Lupus Erythematosus-Related Anemia

被引:22
|
作者
Jiang, Peipei [1 ]
Bian, Maohong [1 ]
Ma, Wenjuan [2 ]
Liu, Chunqiu [1 ]
Yang, Peng [1 ]
Zhu, Bangqiang [1 ]
Xu, Yuanhong [3 ]
Zheng, Meijuan [3 ]
Qiao, Jinpin [3 ]
Shuai, Zongwen [4 ]
Zhou, Xueyong [5 ]
Huang, Dake [6 ]
机构
[1] Anhui Med Univ, Affiliated Hosp 1, Dept Blood Transfus, 218 Ji Xi Rd, Hefei 230022, Anhui, Peoples R China
[2] Hangzhou Elderly Hosp, Dept Lab Med, Hangzhou, Zhejiang, Peoples R China
[3] Anhui Med Univ, Affiliated Hosp 1, Dept Lab Med, Hefei, Anhui, Peoples R China
[4] Anhui Med Univ, Affiliated Hosp 1, Dept Rheumatism & Immunol, Hefei, Anhui, Peoples R China
[5] Blood Ctr Anhui Prov, Hefei, Anhui, Peoples R China
[6] Anhui Med Univ, Integrated Lab, Hefei, Anhui, Peoples R China
关键词
Anemia; Eryptosis; Phosphatidylserine; Calcium; Reactive oxygen species; Systemic lupus erythematosus; SUICIDAL ERYTHROCYTE DEATH; OXIDATIVE STRESS; MITOCHONDRIAL DYSFUNCTION; CELLS; CHANNELS;
D O I
10.1159/000453191
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background: The progression of systemic lupus erythematosus (SLE) leads to anemia in patients, adversely affecting prognosis. The diverse causes of anemia may include excessive eryptosis or premature suicidal erythrocyte death characterized by cell shrinkage and phosphatidylserine (PS) exposure on the cell surface. The present study explored if SLE enhances eryptosis and the underlying mechanisms. Materials and Methods: Eryptosis was assessed using flow cytometry in healthy volunteers (n = 20) and anemic patients hospitalized for SLE (n = 22), for parameters including PS exposure, cell volume, cytosolic calcium ion (Ca2+) levels and reactive oxygen species (ROS) and ceramide abundance. These indicators were measured in erythrocytes of experimental subjects and erythrocytes treated with plasma from healthy volunteers or SLE patients. Results: The hemoglobin and hematocrit levels were significantly lower in anemic SLE patients than in healthy volunteers (***p<0.001, p<0.001, respect)vely). The percentage of PS-exposing erythrocytes was significantly higher in SLE patients than in healthy volunteers (p < 0.001), accompanied by an increase in cytosolic Ca2e levels, oxidative stress. The measurements of PS and Ca2e levels were significantly higher in the erythrocytes of healthy volunteers following incubation in plasma of SLE patients than in plasma of healthy volunteers for 24h (***p <0.001, * p < 0.05 respectively). Conclusion: Eryptosis is enhanced in SLE and may contribute to anemia. The probable underlying mechanisms may be an excessive formation of ROS in erythrocytes. Also, some plasma components may trigger eryptosis by increasing the cytosolic Ca2+ concentration. (C) 2016 The Author(s) Published by S. Karger AG, Basel
引用
收藏
页码:1391 / 1400
页数:10
相关论文
共 50 条
  • [31] SYSTEMIC LUPUS ERYTHEMATOSUS-RELATED AUTOANTIBODY PRODUCTION IN MICE IS DETERMINED BY BONE-MARROW-DERIVED CELLS
    LEVITE, M
    ZINGER, H
    MOZES, E
    REISNER, Y
    BONE MARROW TRANSPLANTATION, 1993, 12 (03) : 179 - 183
  • [32] APLASTIC-ANEMIA IN SYSTEMIC LUPUS-ERYTHEMATOSUS - A CELLULAR IMMUNE MECHANISM
    ROFFE, C
    CAHILL, MR
    SAMANTA, A
    BRICKNELL, S
    DURRANT, STS
    BRITISH JOURNAL OF RHEUMATOLOGY, 1991, 30 (04): : 301 - 304
  • [33] An uncommon cause of anemia in systemic lupus erythematosus
    Singh, Abhijai
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2013, 16 (06) : 783 - 785
  • [34] Anti-high-density lipoprotein antibodies and lipoprotein characteristics in systemic lupus erythematosus-related cardiovascular disease
    Su, J.
    Cederholm, A.
    Hurt-Camejo, E.
    Svenungsson, E.
    Frostegard, J.
    ARTHRITIS RESEARCH & THERAPY, 2005, 7 (Suppl 1) : S40 - S40
  • [35] Cyclophosphamide in the Treatment of Systemic Lupus Erythematosus-related Guillain-Barre Syndrome: A Systematic Review of Case Reports
    Xiong, Anji
    Cui, Hongxu
    Deng, Ruiting
    Wei, Xin
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2023, 18 (03) : 285 - 293
  • [36] Anti-high-density lipoprotein antibodies and lipoprotein characteristics in systemic lupus erythematosus-related cardiovascular disease
    J Su
    A Cederholm
    E Hurt-Camejo
    E Svenungsson
    J Frostegård
    Arthritis Research & Therapy, 7
  • [37] Cyclophosphamide in the Treatment of Systemic Lupus Erythematosus-related Guillain-Barré Syndrome: A Systematic Review of Case Reports
    Anji Xiong
    Hongxu Cui
    Ruiting Deng
    Xin Wei
    Journal of Neuroimmune Pharmacology, 2023, 18 : 285 - 293
  • [38] INDIRECT COSTS OF SYSTEMIC LUPUS ERYTHEMATOSUS-RELATED ABSENTEEISM IN POLAND: AN ANALYSIS BASED ON SOCIAL INSURANCE INSTITUTION DATA
    Golicki, D.
    Karczewicz, E.
    Zalewska, H.
    Dziurda, D.
    Gryglewicz, J.
    Gierczynski, J.
    VALUE IN HEALTH, 2013, 16 (07) : A386 - A386
  • [39] Screening of Potential Circulating Diagnostic Biomarkers and Molecular Mechanisms of Systemic Lupus Erythematosus-Related Myocardial Infarction by Integrative Analysis
    Ding, Haoran
    Zhu, Guoqi
    Lin, Hao
    Chu, Jiapeng
    Yuan, Deqiang
    Yao, Yi'an
    Gao, Yanhua
    Chen, Fei
    Liu, Xuebo
    JOURNAL OF INFLAMMATION RESEARCH, 2023, 16 : 3119 - 3134
  • [40] Successful Use of Bronchoscopic Recombinant Activated Factor VII in the Treatment of Systemic Lupus Erythematosus-Related Diffuse Alveolar Hemorrhage
    Zeman, Joseph
    Sadowski, Brett
    Shemer, John
    CHEST, 2015, 148 (04)